HC...nah it had a slight change of course in that it was determined to really get across the line in terms of a TGA provisional approval, more than a std of care needed to be shown. Example:Pain
Function
One more advantage to determine it to be better, novel and some greater benefit than a combo of whats already out there (nevermind the side effects and limitations of the current std of care etc).
This extra thing is now determined to be DMOAD....we show this in our current 008 study and we can apply on the strength of the forthcoming data.
DYOR
HC...nah it had a slight change of course in that it was...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $66.54M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 19.0¢ | $203.4K | 1.019M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 387930 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 65468 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |